Sorrento Therapeutics Inc
Change company Symbol lookup
Select an option...
SRNEQ Sorrento Therapeutics Inc
SPI SPI Energy Co Ltd
AMC AMC Entertainment Holdings Inc
BOF BranchOut Food Inc
KITT Nauticus Robotics Inc
EAT Brinker International Inc
JCSE JE Cleantech Holdings Ltd
GVP GSE Systems Inc
CURV Torrid Holdings Inc
APRN Blue Apron Holdings Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the next-generation of cancer therapeutics. The Scilex segment is organized around its non-opioid pain management operations and clinical pipeline. The Company’s immuno-oncology platforms, including its fully human antibodies (G-MAB library), ACEA small molecule library, immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs) and oncolytic virus (Seprehvec). The Company is also developing potential antiviral therapies against COVID-19, including FUJOVEE (Abivertinib) and its rapid diagnostic test, including COVIMARK.

Closing Price
$0.094
Day's Change
-0.0062 (-6.19%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.1151
Day's Low
0.086
Volume
(Below Average)
Volume:
3,495,089

10-day average volume:
4,279,076
3,495,089

Thinking about trading options or stock in Crinetics Pharmaceuticals, Tesla, Rtx Corp, Palantir Technologies, or Amazon.com?

9:31 am ET September 11, 2023 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for CRNX, TSLA, RTX, PLTR, and AMZN.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- CRNX: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=CRNX&prnumber=091120231

-- TSLA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=TSLA&prnumber=091120231

-- RTX: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=RTX&prnumber=091120231

-- PLTR: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PLTR&prnumber=091120231

-- AMZN: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=AMZN&prnumber=091120231

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG05628&sd=2023-09-11

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-crinetics-pharmaceuticals-tesla-rtx-corp-palantir-technologies-or-amazoncom-301923271.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG05628&Transmission_Id=202309110931PR_NEWS_USPR_____CG05628&DateId=20230911

comtex tracking

COMTEX_439967292/1005/2023-09-11T09:31:27

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.